is a glp 1 right for me Which GLP-1 Me? Choosing Your Medication Understanding semaglutide (GLP-1 RA): Are

doi:10.5826/dpc.0801a04, ( Sastre, J., Pallard, F.V

During fasting windows, the medication's appetite-suppressing effect makes it psychologically easier to maintain caloric restriction without experiencing intense hunger

The SELECT trial, published in 2024, showed that semaglutide reduced major adverse cardiovascular events (MACE: heart attack, stroke, cardiovascular death) by 20% in individuals with obesity, even independent of weight loss magnitude. Why

Rather than treating all patients the same, healthcare is moving toward personalized approaches that prioritize both outcomes and quality of life

People in the combination SGLT2i with semaglutide OW T2D group had 0.81%, 0.74%, and 0.79% greater reductions in HbA 1c from baseline at 6 (Fig

These financial barriers can deter women from seeking timely medical care, potentially leading to untreated conditions and worsening health outcomes